|
QLIFE®
CASTAGNUS®
Herbal Dietary Supplement
TABLETS
ACCORDING TO
CLINICAL STUDY, INDICATED FOR
(click here => to
read the report):
-
(PMS) PREMENSTRUAL SYNDROME
-
CYCLIC MASTALGIA (cyclic
mastitis or painful swelling of breasts)
-
CERTAIN MENSTRUAL CYCLE
PROBLEMS
-
FACIAL ACNE
Directions:
Healthy females under
130 lb. may take one (1) and those over 130 lb. two (2) tablets by mouth,
in the morning, with a glass of fluid (water, juice, milk, etc.) for 90
days.
Contraindications:
Pregnancy, suspected
pregnancy, and breast feeding
Warning:
Keep out
of reach of children.
Keep in
dry place. Do not expose to light.
Regular
use only on advice of a health professional.
The potency
of the supplement may increase when taken concurrently with a birth
control pill.
Guaranteed
Content of Active Ingredient:
Dry Chasteberry ( Agni casti fructus) standardized extract
- 45 mg. One tablet contains 0.3 mg of iridoid glycosides (on aucubin
basis)
Excipients
(inactive ingredients or standard tablet forming materials, such as: potato
starch, lactose, polyvidon, magnesium stearate):
155 mg
Supposed
Action:
PMS and
certain menstrual cycle disturbances are attributed to hyperprolactinemia,
i.e., a condition of elevated serum prolactin. Castagnus®
tablets stimulate dopaminergetic receptors and lower prolactin (secreted
from the pituitary gland) levels.
Side Effects:
Marginal
number of subjects (6%) in the clinical study had nausea in the first week
of use.
How Supplied:
30 tablets
(3 blister packs)
Disclaimer:
The above
claims have not been evaluated by the US FDA.
Castagnus®
tablets are not intended to diagnose, prevent, treat, or cure any disease.
QLIFE®
is
a registered trademark of BATORY A.M., Inc.
H®
is
a registered trademark of Herbapol
S.A., Wroclaw
Distributed by : BATORY A.M.,
Inc.
QLIFE®
Health
& Beauty Products
Lincoln Park, NJ 07035-0275
|